YLR053C Antibody

What is YLR053C and why is it significant for research?

YLR053C, renamed NRS1 (Nitrogen-Responsive Start regulator 1), is a gene that encodes a poorly characterized 108 amino acid microprotein in Saccharomyces cerevisiae. This recently evolved microprotein has significant research interest as it functions as a key regulator at the Start checkpoint of the cell cycle under nitrogen-limited conditions. YLR053C/NRS1 allows cells to adapt to poor nitrogen environments by rewiring the Start transcriptional machinery, particularly through interaction with the SBF transcription factor (Swi4 and Swi6 proteins) . Understanding YLR053C provides insights into nutrient-responsive cell cycle regulation mechanisms in yeast, which can serve as models for similar processes in more complex organisms.

What experimental applications are YLR053C antibodies validated for?

Currently available YLR053C antibodies, such as the rabbit polyclonal antibody (MBS7189044) against Saccharomyces cerevisiae strain 204508/S288c, have been validated for applications including ELISA and Western Blot . These techniques allow for the detection and quantification of the YLR053C/NRS1 protein in various experimental contexts. Before using YLR053C antibodies in other applications such as flow cytometry or immunoprecipitation, additional validation would be necessary as antibody performance varies significantly between applications .

How can I confirm the specificity of YLR053C antibodies in my experiments?

To confirm specificity, implement multiple validation strategies:

• Control samples: Use extracts from YLR053C/NRS1 knockout strains as negative controls

• Expression pattern verification: YLR053C/NRS1 is specifically expressed under nitrogen limitation or TORC1 inhibition (e.g., rapamycin treatment), so observe whether antibody detection matches this known regulation pattern

• Subcellular localization: Verify that the detected protein shows nuclear localization, consistent with YLR053C's reported localization

• Molecular weight confirmation: Ensure the detected protein band in Western blots corresponds to the expected molecular weight of the 108 amino acid microprotein

• Comparison with tagged versions: If possible, compare detection with strains expressing epitope-tagged versions (e.g., GFP-tagged or MYC-tagged YLR053C) to confirm specificity

What is the optimal protocol for detecting YLR053C using Western blot?

For optimal detection of YLR053C/NRS1 using Western blot:

• Sample preparation: Prepare yeast cell lysates from cultures grown in nitrogen-limited medium (e.g., YNB + 0.4% proline + 2% glucose) or treated with rapamycin (100 nM for 1-2 hours), as YLR053C expression is significantly induced under these conditions

• Controls: Include samples from both rich medium and nitrogen-limited conditions to demonstrate specificity of detection, as YLR053C is not expressed at detectable levels in rich medium

• Gel electrophoresis: Use a higher percentage gel (15-18%) optimized for the separation of small proteins, as YLR053C is only 108 amino acids

• Transfer: Use optimized transfer conditions for small proteins (higher methanol concentration, shorter transfer time)

• Blocking: Block with 5% non-fat dry milk or BSA in TBST

• Primary antibody: Incubate with anti-YLR053C antibody at the validated dilution (typically 1:1000) overnight at 4°C

• Secondary antibody: Use appropriate anti-rabbit HRP-conjugated secondary antibody

• Detection: Employ enhanced chemiluminescence (ECL) for visualization

How should I design experiments to study YLR053C expression under different nutrient conditions?

When designing experiments to study YLR053C expression across nutrient conditions:

• Culture conditions:

  • Rich medium (SC + 2% glucose) as negative control

  • Nitrogen-limited medium (YNB + 0.4% proline + 2% glucose) for induced expression

  • Rapamycin treatment (100 nM) in rich medium to mimic nitrogen limitation response

  • Various carbon sources with controlled nitrogen availability to assess specificity to nitrogen rather than general nutrient limitation

• Time course analysis:

  • Short-term (1-7 hours) and long-term (overnight, 22+ hours) exposure to nitrogen limitation, as YLR053C expression requires extended nitrogen limitation

  • Temporal sampling after rapamycin addition (30 min, 1 hour, 2 hours, etc.)

• Detection methods:

  • Western blot using validated anti-YLR053C antibodies

  • RT-qPCR to monitor transcript levels in parallel

  • If possible, microscopy of cells expressing fluorescently-tagged YLR053C

• Controls:

  • Strains with known YLR053C expression patterns

  • Other stress conditions (osmotic stress, oxidative stress, DNA damage) as negative controls that don't induce YLR053C

Can YLR053C antibodies be used for immunoprecipitation studies of protein-protein interactions?

While specific validation data for using YLR053C antibodies in immunoprecipitation is not explicitly provided in the search results, the approach can be adapted based on known interactions of YLR053C:

• Feasibility: As YLR053C/NRS1 has been demonstrated to physically interact with SBF (Swi4 and Swi6) through co-immunoprecipitation experiments with epitope-tagged versions , antibodies against the native protein could potentially be used for similar studies

• Recommended approach:

  • Perform initial validation comparing immunoprecipitation efficiency between nitrogen-limited (YLR053C expressing) and rich media conditions (non-expressing)

  • Confirm specific pull-down by Western blot

  • For interaction studies, analyze co-precipitated proteins for known partners (Swi4 and Swi6)

  • Consider crosslinking for transient interactions

• Control experiments:

  • Include IgG control immunoprecipitations

  • Compare results with epitope tag-based immunoprecipitation if available

  • Include samples from YLR053C deletion strains

How can I use YLR053C antibodies to study the evolutionary adaptation of microproteins in yeast species?

To study evolutionary aspects of YLR053C using antibodies:

• Cross-species reactivity analysis:

  • Test YLR053C antibody reactivity against extracts from closely related Saccharomyces species (S. mikatae, S. bayanus, S. castellii) where YLR053C shows rapid evolution (high dN/dS ratios)

  • Assess conservation of expression patterns under nitrogen limitation across species

  • Determine whether the 17 amino acid conserved C-terminal domain is sufficient for antibody recognition

• Functional conservation study:

  • Use antibodies to assess protein expression levels of YLR053C orthologs

  • Combine with functional assays to correlate expression with phenotypic effects

  • Examine whether post-translational modifications differ between species

• Evolution of regulation:

  • Compare induction kinetics of YLR053C protein across species in response to nitrogen limitation

  • Correlate findings with evolutionary divergence data to identify selection pressures

• Methodological considerations:

  • For cross-species studies, focus on epitopes within the conserved regions

  • Consider generating new antibodies against conserved epitopes if current antibodies don't recognize orthologs

  • Complement antibody-based studies with genomic and transcriptomic approaches

What techniques can combine YLR053C antibodies with genomic approaches to study its role in transcriptional regulation?

Advanced approaches to study YLR053C's role in transcriptional regulation:

• ChIP-seq using YLR053C antibodies:

  • Optimize chromatin immunoprecipitation protocols for YLR053C under nitrogen-limited conditions

  • Sequence precipitated DNA to identify genomic binding sites

  • Compare binding profiles with known SBF target genes

  • Correlate with transcriptional changes using RNA-seq

• CUT&RUN or CUT&Tag approaches:

  • These methods often provide higher resolution than traditional ChIP

  • Can be performed with fewer cells, which is beneficial given the condition-specific expression of YLR053C

  • Protocol modification: induce YLR053C expression with rapamycin or nitrogen limitation before performing the technique

• Proximity-labeling approaches:

  • Use antibodies to validate proximity-labeling results (BioID or APEX2 fused to YLR053C)

  • Identify the complete interactome of YLR053C under different nutrient conditions

  • Compare with SBF complex components and other transcriptional regulators

• Integrated analysis:

  • Correlate binding sites with changes in cell cycle progression

  • Map the relationship between YLR053C binding and Whi5 displacement from SBF

  • Create network models of YLR053C-dependent transcriptional changes

Why might I fail to detect YLR053C protein in nitrogen-limited conditions?

If you're unable to detect YLR053C under conditions where it should be expressed:

• Insufficient induction time: YLR053C requires extended exposure to nitrogen limitation (>22 hours) to reach detectable levels in some strains; short exposures (7 hours or less) may be insufficient

• Strain differences: Confirm your strain background, as expression levels may vary between laboratory strains

• Antibody epitope accessibility issues:

  • YLR053C is a small protein that may fold in ways that obscure antibody epitopes

  • Try different lysis methods or denaturing conditions

  • Consider using epitope-tagged versions as positive controls

• Technical considerations:

  • For Western blot, ensure appropriate gel percentage for small proteins

  • Verify transfer efficiency for small proteins

  • Increase exposure time during detection

  • Consider using signal enhancement systems

• Degradation issues:

  • Add protease inhibitors immediately during sample collection

  • Process samples quickly and maintain cold temperatures

  • Consider analyzing nuclear fractions specifically, as YLR053C localizes to the nucleus

How can I distinguish between specific and non-specific binding when using YLR053C antibodies?

To distinguish specific from non-specific binding:

• Essential controls:

  • YLR053C deletion strain samples as negative controls

  • Rich media conditions where YLR053C is not expressed

  • Blocking peptide competition assays to confirm specificity

• Validation approach:

  • Compare detection patterns between rapamycin-treated and untreated samples

  • Verify nuclear localization consistent with YLR053C function

  • Confirm molecular weight matches expected size

• Technical optimization:

  • Titrate antibody concentration to minimize background

  • Increase washing stringency if background is high

  • Try alternative blocking agents (BSA vs. milk)

  • For microscopy, include secondary-only controls

• Confirmatory approaches:

  • Compare with epitope-tagged version signal pattern

  • Validate with orthogonal detection methods (mass spectrometry)

  • Use multiple antibodies targeting different regions if available

How do findings from YLR053C studies relate to understanding nutrient sensing in higher eukaryotes?

YLR053C/NRS1 research provides insights into fundamental cellular processes that can be applied to higher organisms:

• Conservation of regulatory principles:

  • While YLR053C itself is a recently evolved microprotein , the regulatory mechanisms affecting cell cycle in response to nutrients are broadly conserved

  • The interaction between YLR053C and SBF parallels relationships between nutrient-sensing pathways and cell cycle regulators in metazoans

  • YLR053C studies highlight how cells integrate nutritional cues with proliferation decisions

• Translational relevance:

  • Understanding how YLR053C mediates TORC1 signaling effects on cell cycle may provide insights into mTOR pathway functions in human cells

  • The nitrogen-responsive nature of YLR053C relates to amino acid sensing mechanisms in mammalian cells

  • Small regulatory proteins like YLR053C are increasingly recognized across species as important biological regulators

• Methodological applications:

  • Antibody-based approaches validated in YLR053C research can be adapted to study nutrient-responsive microproteins in other organisms

  • Multi-level analysis (genomic, transcriptomic, proteomic) demonstrated in YLR053C studies provides a framework for similar investigations in complex systems

What considerations are important when developing new antibodies against microproteins like YLR053C?

Developing effective antibodies against microproteins requires specialized approaches:

• Antigen design challenges:

  • Limited epitope options due to small protein size (108 amino acids for YLR053C)

  • Need to identify regions with high antigenicity while avoiding highly conserved domains that might cross-react

  • Consider using full-length recombinant protein as immunogen rather than peptides

  • For cross-species studies, target the conserved C-terminal 17 amino acid region

• Validation considerations:

  • Essential to validate under conditions where expression is confirmed (nitrogen limitation, rapamycin treatment)

  • Include knockout controls to confirm specificity

  • Validate across multiple applications (Western blot, immunoprecipitation, etc.)

  • Test fixation sensitivity if intended for microscopy applications

• Application-specific optimization:

  • As emphasized by Proteintech Group's approach, application-focused antibody development significantly improves performance

  • Antibodies designed for one application (e.g., ELISA) may not work in others (e.g., flow cytometry)

  • For microproteins, consider specialized validation approaches beyond standard methods

• Technical approach recommendations:

  • Use carrier proteins for immunization due to small size of target

  • Consider rabbit host for higher affinity and specificity

  • Test multiple clones when developing monoclonal antibodies

  • Include extensive affinity purification steps to minimize cross-reactivity